FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3132290736> ?p ?o ?g. }

• W3132290736 endingPage "6606" @default.
• W3132290736 startingPage "6597" @default.
• W3132290736 abstract "The severe acute respiratory syndrome coronavirus 2 that causes coronavirus disease 2019 (COVID-19) binds to the angiotensin-converting enzyme 2 (ACE2) to gain cellular entry. Akt inhibitor triciribine (TCBN) has demonstrated promising results in promoting recovery from advanced-stage acute lung injury in preclinical studies. In the current study, we tested the direct effect of TCBN on ACE2 expression in human bronchial (H441) and lung alveolar (A549) epithelial cells. Treatment with TCBN resulted in the downregulation of both messenger RNA and protein levels of ACE2 in A549 cells. Since HMGB1 plays a vital role in the inflammatory response in COVID-19, and because hyperglycemia has been linked to increased COVID-19 infections, we determined if HMGB1 and hyperglycemia have any effect on ACE2 expression in lung epithelial cells and whether TCBN has any effect on reversing HMGB1- and hyperglycemia-induced ACE2 expression. We observed increased ACE2 expression with both HMGB1 and hyperglycemia treatment in A549 as well as H441 cells, which were blunted by TCBN treatment. Our findings from this study, combined with our previous reports on the potential benefits of TCBN in the treatment of acute lung injury, generate reasonable optimism on the potential utility of TCBN in the therapeutic management of patients with COVID-19." @default.
• W3132290736 created "2021-03-01" @default.
• W3132290736 creator A5042136937 @default.
• W3132290736 creator A5048447444 @default.
• W3132290736 creator A5052840597 @default.
• W3132290736 creator A5071358448 @default.
• W3132290736 creator A5088952922 @default.
• W3132290736 date "2021-02-24" @default.
• W3132290736 modified "2023-09-27" @default.
• W3132290736 title "Akt‐independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS‐CoV2 infection" @default.
• W3132290736 cites W1896616612 @default.
• W3132290736 cites W1961536135 @default.
• W3132290736 cites W1961839152 @default.
• W3132290736 cites W1969936268 @default.
• W3132290736 cites W1991545574 @default.
• W3132290736 cites W1991557988 @default.
• W3132290736 cites W1994566639 @default.
• W3132290736 cites W2003590580 @default.
• W3132290736 cites W2027171193 @default.
• W3132290736 cites W2062750943 @default.
• W3132290736 cites W2076042473 @default.
• W3132290736 cites W2083250117 @default.
• W3132290736 cites W2091671824 @default.
• W3132290736 cites W2094536853 @default.
• W3132290736 cites W2103969450 @default.
• W3132290736 cites W2105445695 @default.
• W3132290736 cites W2145482724 @default.
• W3132290736 cites W2152575820 @default.
• W3132290736 cites W2261269965 @default.
• W3132290736 cites W2418624275 @default.
• W3132290736 cites W2557860064 @default.
• W3132290736 cites W258796069 @default.
• W3132290736 cites W2792452770 @default.
• W3132290736 cites W2907869690 @default.
• W3132290736 cites W2944485914 @default.
• W3132290736 cites W2988197128 @default.
• W3132290736 cites W3008273325 @default.
• W3132290736 cites W3009859788 @default.
• W3132290736 cites W3009912996 @default.
• W3132290736 cites W3013442544 @default.
• W3132290736 cites W3015134137 @default.
• W3132290736 cites W3017331996 @default.
• W3132290736 cites W3017620015 @default.
• W3132290736 cites W3018519133 @default.
• W3132290736 cites W3021640348 @default.
• W3132290736 cites W3022842703 @default.
• W3132290736 cites W3023334190 @default.
• W3132290736 cites W3023389479 @default.
• W3132290736 cites W3024339709 @default.
• W3132290736 cites W3025700923 @default.
• W3132290736 cites W3026032531 @default.
• W3132290736 cites W3027129397 @default.
• W3132290736 cites W3028772481 @default.
• W3132290736 cites W3029158812 @default.
• W3132290736 cites W3032373213 @default.
• W3132290736 cites W3033323575 @default.
• W3132290736 cites W3037185429 @default.
• W3132290736 cites W3038168288 @default.
• W3132290736 cites W3038478783 @default.
• W3132290736 cites W3044416430 @default.
• W3132290736 cites W3089573304 @default.
• W3132290736 cites W3091868035 @default.
• W3132290736 cites W3096830442 @default.
• W3132290736 cites W3111167672 @default.
• W3132290736 cites W3115793677 @default.
• W3132290736 cites W3132290736 @default.
• W3132290736 cites W438790120 @default.
• W3132290736 cites W69767800 @default.
• W3132290736 cites W154735814 @default.
• W3132290736 doi "https://doi.org/10.1002/jcp.30343" @default.
• W3132290736 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8014085" @default.
• W3132290736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33624300" @default.
• W3132290736 hasPublicationYear "2021" @default.
• W3132290736 type Work @default.
• W3132290736 sameAs 3132290736 @default.
• W3132290736 citedByCount "6" @default.
• W3132290736 countsByYear W31322907362021 @default.
• W3132290736 countsByYear W31322907362022 @default.
• W3132290736 countsByYear W31322907362023 @default.
• W3132290736 crossrefType "journal-article" @default.
• W3132290736 hasAuthorship W3132290736A5042136937 @default.
• W3132290736 hasAuthorship W3132290736A5048447444 @default.
• W3132290736 hasAuthorship W3132290736A5052840597 @default.
• W3132290736 hasAuthorship W3132290736A5071358448 @default.
• W3132290736 hasAuthorship W3132290736A5088952922 @default.
• W3132290736 hasBestOaLocation W31322907361 @default.
• W3132290736 hasConcept C104317684 @default.
• W3132290736 hasConcept C126322002 @default.
• W3132290736 hasConcept C127561419 @default.
• W3132290736 hasConcept C203014093 @default.
• W3132290736 hasConcept C2775946041 @default.
• W3132290736 hasConcept C2776914184 @default.
• W3132290736 hasConcept C2777648638 @default.
• W3132290736 hasConcept C2777714996 @default.
• W3132290736 hasConcept C2779134260 @default.
• W3132290736 hasConcept C2780545709 @default.
• W3132290736 hasConcept C3008058167 @default.
• W3132290736 hasConcept C502942594 @default.

• next